NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
NHS England
This tender has closed
The submission deadline for this contract has passed. There may be more active services tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS England awarded this contract to ITH Pharma | Qualasept Ltd t/a Bath ASU | Sciensus Pharma Services Limited | Baxter Healthcare Ltd | LloydsPharmacy Clinical Homecare | Quantum Pharmaceutical worth £608,000,000 on 11 Mar 2024. The contract runs until 31 Mar 2028.
Description
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01
Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Awarded suppliers (6)
- ITH Pharma
- Qualasept Ltd t/a Bath ASU
- Sciensus Pharma Services Limited
- Baxter Healthcare Ltd
- LloydsPharmacy Clinical Homecare
- Quantum Pharmaceutical
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c • Added 3 October 2026